News | ECMO Systems | February 22, 2018

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

ECMO-based protocol improves sudden cardiac arrest survival from 0 to 40 percent

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

February 22, 2018 — When someone goes into cardiac arrest and first responders cannot shock their heart back into rhythm, there is virtually no chance of survival. However, a new protocol being tested at The Ohio State University Wexner Medical Center is already saving lives – increasing survival rates from zero to about 40 percent.

“It’s astounding that patients are able to fully recover and walk out of the hospital when they would have been pronounced dead in the field before this protocol was in place,” said K. Dean Boudoulas, M.D., a cardiologist and assistant professor of internal medicine at The Ohio State University Wexner Medical Center.

The extracorporeal cardiopulmonary resuscitation (ECPR) protocol was developed through a partnership with the Columbus Division of Fire. It is initiated by EMS if they are not able to restore normal rhythm after shocking a patient’s heart three times. After alerting the hospital, emergency personnel connect the patient to a device that automatically delivers CPR to preserve the patient’s brain and organ function on the way to the hospital. Upon arrival, the patient bypasses the emergency room and is taken straight to the heart catheterization lab where they are connected to an extracorporeal membrane oxygenation (ECMO) machine.

“This allows the heart and lungs to rest while doctors perform a heart catheterization to find the problem, which is usually a blocked artery,” said Bryan Whitson, M.D., Ph.D., director of the Collaboration for Organ Perfusion, Protection, Engineering and Regeneration at Ohio State.

With positive results from this and other pilot studies, experts hope that the protocol will become standard care in treating cardiac arrests.

Watch the VIDEO: Ohio State University Introduces ECMO Protocol for Cardiac Arrest

For more information: www.wexnermedical.osu.edu

 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init